Archive for June, 2003

RNAi Firms Stake Their Claims

RNAi Firms Stake Their Claims First there was gene splicing. Next came monoclonal antibodies. And now, RNA interference, or gene silencing, has taken the scientific community by storm. Reportedly, RNA interference technology has revolutionized the practice of molecular biology – and the excitement it has generated continues to mount


More U.S. Investment in Biotech Needed, USAID Chief Says

More U.S. Investment in Biotech Needed, USAID Chief Says The United States and the international community should continue to invest more in the development of new agricultural technologies — including biotechnology — to prevent millions more Africans from becoming malnourished and vulnerable to disease and infection, says Andrew Natsios, administrator of the U.S. Agency for […]


Biotech Investors: When Will They Ever Learn?

Biotech Investors: When Will They Ever Learn? Investors should get a grip on reality. Many small companies that were lifted on the latest news are strapped for cash and pursuing risky science that will take years to bear fruit. Even for big players, good trial data on a drug don’t guarantee Food & Drug Administration […]


Drug ads deliver a few side effects

Drug ads deliver a few side effects Drug companies tripled their advertising budgets in recent years to acquaint American consumers with things like acid reflux disease, depression, erectile dysfunction, and even toenail fungus, a marketing blitz that accounted for roughly 12 percent of the growth in national prescription drug spending in 2000, according to a […]